[1] TOKAIRIN T,NISHIKAWA Y,WATANABE H, et al. Osteopontin expression in the liver with severe perisinusoidal fibrosis:autopsy case of Down syndrome with transient myeloproliferative disorder[J]. Pathol Int,2008,58(1):64-68. [2] ROCKEY DC. Hepatic blood flow regulation by stellate cells in normal and injured liver[J]. Semin Liver Dis,2001,21(3):337-343. [3] TIPOE GL,LIONG EC,CASEY CA,et al. A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury[J]. 2008,32(4):669-682. [4] El-BASSIOUNY AE,ZOHEIRY MM,NOSSEIR MM,et al. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma[J]. Med Gen Med,2007,9(3):45. [5] BREINIG M,SCHIRMACHER P,KERN MA. Cyclooxygenase-2(COX- 2 )-a therapeutic target in liver cancer[J]. Curr Pharm Des,2007,13(32):3305-3315. [6] EIZAYAGA FX,AGUEJOUF O,DESPLAT V,et al. Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension[J]. World J Gastroenterol,2007,13(38):5065-5070. [7] PISTON D,WANG S,FENG Y,et al. The role of cyclooxygenase-2/prostanoid pathway in visceral pain induced liver stress response in rats[J]. Chin Med J (Engl),2007,120(20):1813-1819. [8] HORRILLO R,PLANAGUMO A,GONZALEZ-PERIZ A,et al. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor[J]. J Pharmacol Exp Ther,2007,323(3):778-786. [9] BATALLER R,GINES P,NICOLAS JM,et,al. Angioensin II induces contraction and proliferation of human hepaticstellatecells[J]. Gastroenterology,2000,118:1149-1156. [10] 张晶,宗春华,李定国,等. 肝星形细胞存在局部肾素-血管紧张素-醛固酮系统[J]. 中华消化杂志,2003,21:38-40. |